Edith Olah - Curriculum Vitae#

Professor of Molecular Genetics
Head, Dept Molecular Genetics; National Institute of Oncology, Budapest, Hungary

SCIENTIFIC DEGREES:

• Member, Hungarian Academy of Sciences (HAS) (2007)
  
• D.Sc. on molecular cell biology and oncology, HAS (1992)
  
• PhD (genetics), Eötvös L Univ, Budapest, Hungary (1974)

RESEARCH INTEREST:
1) Molecular mechanisms of oncogenesis with a focus on genetic predisposition to cancer 2) Cancer susceptibility genes in Central-Eastern Europe
OTHER ACTIVITY:

Genetic testing for inherited cancer risk (breast & colorectal)

PUBLICATIONS:

Author of 137 peer-reviewed papers, mostly on molecular cancer genetics. Over 4000 citations, H-index 37 (IF= 407.594)

ADMINISTRATIVE FUNCTIONS IN RUNNING CANCER SOCIETIES and ORGANIZATIONS in last decade:

• President, European Association for Cancer Research (EACR)
  
• Chair, Eur Coalition for Biom Res
  
• Coordinator, Central and Eastern European Cancer Genetics Network
  
• Consultant/Reviewer, European Commission
  
• Chair, Eur Study Group for Cell Proliferation/Eur Cell Proliferation Soc
  
• Chair, Fellowship Comm, Int Agency for Research on Cancer, Lyon, France
  
• President, Hungarian Cancer Society
  
• Chair/Member, COMMITTEES of Am Assoc Cancer Res (AACR), incl. those on Scientific Programs, Special Conferences, Career Development Award Selection, Susan G Komen Found Award; Pezcoller Award, Kirk Landon Award

ADVISORY BOARDS for European cancer organizations (EACR, FECS/ECCO etc.) & for EC (“Cancer in FP7”)

EDITORIAL BOARD member of 6 international journals (incl. Mol Oncol, Mol Cancer Res)

TEACHING:

• Professor, Inv lecturer, Eötvös L & Semmelweis Univ, Budapest;
  
• Visiting Professor, Lab Exp Oncol, IUPUI Sch Med, Indianapolis, IN, USA
  
• Supervisor of 10 Ph.D. THESIS works

TRAINING of 13 visiting scientists from 6 countries of Central -Eastern Europe, USA, NL

INTERNATIONAL COLLABORATIONS/GRANTS (5 continents, 41 groups)

• „Genomic Approaches in Cancer Care”(A-L Borresen-Dale, Norwegian Financing Mech)
  
• The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
  
• International BRCA1/2 Carrier Cohort Study (IBCCS)
  
• Fogarty Grant: „Familial Breast Cancer”(M-C King, USA)
  
• EC FP5: „Genetics and Epidemiology of Breast Cancer” BCLC/BCAS (P Devilee, NL)
  
• Fogarty Grant: „Metabolic Reprogramming in Cancer” (G Weber, IUPUI, Sch Med, USA)